McCann Health Engagement
As a media agency exclusively focused on healthcare, McCann Health Engagement has deep knowledge and vast experience planning and buying in the pharmaceutical industry specific to HCP and DTC on a global scale. We have experience working on almost every therapeutic category within the healthcare and pharmaceutical landscape.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
CMI Media Group
CMI Media Group, a WPP company, is a full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group’s core offerings include Audience Strategy, Planning, Development, and…
Four Agency Worldwide
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with content creators, PR gurus with advertising geniuses & sector specialists…
Havas Lynx
We are the Havas Lynx. Devoted to fresh thinking. Changing the way the world does healthcare communications for the better. Great talent. Great ideas. Great outcomes.
MDNT
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
Company Details
Latest Content from PMHub
Knowing your audience is key to successful medical education
Press Releases | September 7, 2016 | Lucid Group Communications Limited
Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...
How to enable each healthcare professional to fully understand your product
White Papers and Resources | September 7, 2016 | Anthill
Read these three articles to understand how working at an individual level benefits all customers:
Alzheimer’s disease: reviewing the immediate treatment horizon
White Papers and Resources | September 1, 2016 | Blue Latitude Health
Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.
A stumble, but not a fall – what’s next for Opdivo?
White Papers and Resources | August 25, 2016 | Blue Latitude Health
Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results.
Meet Anthill at conferences in London
White Papers and Resources | August 19, 2016 | Anthill
October, the month of multichannel pharma marketing in London. Meet us at DigiPharm and Multichannel Excellence Summit
Immuno-oncology; bringing patients closer to treatment
White Papers and Resources | August 18, 2016 | Blue Latitude Health
What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment?
Therapy Watch market snapshots
White Papers and Resources | August 12, 2016 | Inizio
Therapy Watch is a ‘real-time’ syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed,...
Case Study: Private market opportunity for a travel vaccine
White Papers and Resources | August 12, 2016 | Inizio
Our client needed exploratory research to determine the global opportunity for a new travel vaccine in the private market. It was crucial to determine:Which markets had the highest potential to...
Infographic: Conference Live
White Papers and Resources | August 12, 2016 | Inizio
Conference Live gives you real-time insights, utilising the multimedia functionality of the smartphone in an innovative mobile app methodology. We conduct mobile conference research amongst physicians attending conferences, giving our clients...
Blog: The Cost of Counterfeits
White Papers and Resources | August 12, 2016 | Inizio
The sale of counterfeit drugs is growing at twice the rate of legitimate pharmaceuticals and pharma companies stand to lose more than just profits from the fallout of counterfeit identification.